生命科学资讯

Evinova reels in AI clinical development deals with Astellas and AstraZeneca

FDA freezes enrollment in MacroGenics cancer trial after patient death

Harbour ships CTLA-4 asset to form new biotech in $1.1B biobucks deal

Agilent Technologies, Inc. (A) Sparks Confidence With Latest Approvals - Finviz

Assessing Agilent Technologies (A) Valuation As Earnings Approach And New FDA Diagnostic Approval Draws Interest - simplywall.st

UCLA spinout raises $11M to test microbiome-based weight loss therapy

Thermo Fisher Scientific Inc. (TMO) Carries a Mid-Single Digit Organic Growth Forecast - Insider Monkey

Illumina Launches TruPath Genome Workflow Solution - marketscreener.com

Debbie Dingell makes transaction in Waters Corporation stocks from her brokerage account - Investing.com

Can the ACCESS pilot crack a longstanding barrier for startups?

Vir climbs on Astellas deal, study results for ‘masked’ T cell engager

Illumina's TruPath Genome offers rapid whole genome testing for rare disease - Stock Titan

Illumina launches TruPath Genome, setting a new standard in genomic insight - PR Newswire

Astellas and Vir in $1.3B deal for CD3 T-cell engager

Innovacell’s $91M Tokyo IPO to fund incontinence cell therapies

Other news to note for Feb. 24, 2026

Thermo Fisher Scientific introduces kit enabling protein, DNA and RNA analysis from a single sample - R&D World

BioMarin fails to find buyer, pulls Roctavian gene therapy off market

NovaSeq X Series innovation roadmap - Illumina

Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference - PharmiWeb.com